Comprehensive Obesity Care Provided by the Primary Care Physician

“The global obesity epidemic calls for multiple treatment options.
Not every patient qualifies for or tolerates injectable therapies.”
Dr. med. A.Domdey (Coordinator Team GLP- 1 weiterdenken)

Despite the global focus on new prescription weight-loss medications (e.g., GLP-1 agonists), we see significant potential for over-the-counter solutions. The global obesity epidemic calls for multiple treatment options. Not every patient qualifies for or tolerates injectable therapies. formoline L112 offers a unique position here: non-systemic, non-hormonal, and safe for long-term use. It complements the therapeutic spectrum—for example, for patients without access to GLP-1 therapies or for weight maintenance after completion of drug therapy.
We are informing physicians and healthcare decision-makers that formoline represents a unique, safe complement or alternative in the fight against obesity. The global rollout of our campaign “Rethinking GLP-1” for healthcare professionals underscores this strategic positioning.

Producttraining for pharmacies

With the Certmedica expert portal, we offer pharmacies free training on our products. Our modern, time-saving training concept represents maximum success with minimal effort.
Invest just 20 minutes in a brief and enjoyable personal dialogue with us to find out everything you need to know about providing your customers with expert advice and how easy it is to make an active recommendation in practice.

Current offers & campaigns

As a pharmacist, are you interested in current terms for our products and free POS materials?
If so, we would love to hear from you for a one-to-one discussion about how you and your pharmacy can most effectively benefit from our offers.